U-Chart Analysis:Nxera Pharma Co., Ltd.:4565

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Nxera Pharma Co., Ltd. Go to web site 4565 Medicals 東証プライム December 1, 2000 2004.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Nxera Pharma Co., Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Nxera Pharma Co., Ltd. Balance Sheet 2023年12月期 Nxera Pharma Co., Ltd. Balance Sheet 2022年12月期 Nxera Pharma Co., Ltd. Balance Sheet 2021年12月期 Nxera Pharma Co., Ltd. Balance Sheet 2020年12月期 Nxera Pharma Co., Ltd. Balance Sheet 2019年12月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Cash and Cash Equivalents 49,065 66,557 60,087 40,008 15,375
Other Current AssetsHelp 16,047 3,385 2,721 2,010 4,188
Tangible Fixed AssetsHelp 7,900 3,791 3,817 3,824 4,120
Intangible Fixed AssetHelp 52,291 8,577 9,120 11,802 12,999
Investments and OthersHelp 7,272 1,801 6,145 4,687 5,633
Total AssetsHelp 157,198 99,417 96,985 76,465 56,680
Total Current LiabilitiesHelp 23,188 11,923 10,439 7,631 8,412
Total Long-term LiabilitiesHelp 67,200 29,558 29,078 16,453 3,193
Shareholder's EquityHelp 66,810 57,936 57,468 52,381 45,075
Total LiabilitiesHelp 157,198 99,417 96,985 76,465 56,680

Nxera Pharma Co., Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Nxera Pharma Co., Ltd. Profit and Loss Account 2023年12月期 Nxera Pharma Co., Ltd. Profit and Loss Account 2022年12月期 Nxera Pharma Co., Ltd. Profit and Loss Account 2021年12月期 Nxera Pharma Co., Ltd. Profit and Loss Account 2020年12月期 Nxera Pharma Co., Ltd. Profit and Loss Account 2019年12月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Amount of Sales 12,766 15,569 17,712 8,842 9,726
Total Sales 12,766 15,569 17,712 8,842 9,726
Cost of SalesHelp 3,102 926 933 761 761
Other Costs and RevenueHelp 16,857 14,261 15,762 6,602 7,533
Total CostsHelp 19,959 15,187 16,695 7,363 8,294
Net RevenueHelp 9,664 14,643 16,779 8,081 8,965
Earnings Before TaxHelp -10,680 1,078 433 1,622 534
Net IncomeHelp -7,193 382 1,017 1,479 1,432
Net Income -7,193 382 1,017 1,479 1,432

Nxera Pharma Co., Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Nxera Pharma Co., Ltd. Cash Flow Statement 2023年12月期 Nxera Pharma Co., Ltd. Cash Flow Statement 2022年12月期 Nxera Pharma Co., Ltd. Cash Flow Statement 2021年12月期 Nxera Pharma Co., Ltd. Cash Flow Statement 2020年12月期 Nxera Pharma Co., Ltd. Cash Flow Statement 2019年12月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Operating Cash Flow(OFC)Help -5,273 9,952 7,095 4,672 3,441
Investing Cash Flow(ICF)Help -63,791 1,043 278 -150 -246
Financing Cash FlowHelp 48,329 -4,887 11,123 20,278 -6,964
Exchange Difference of Cash and Cash EquivalentsHelp 3,243 362 1,583 -167 384
Net Increase and Decrease in Cash and Cash Equivalentsn -17,492 6,470 20,079 24,633 -3,385

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Nxera Pharma Co., Ltd.

Company where related level is highHelp

Takeda Pharmaceutical Company Limited
SEIKAGAKU CORPORATION
TMS Co.,Ltd.
Oncolys BioPharma Inc.
CHUKYOIYAKUHIN CO.,LTD.
TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
SANTEN PHARMACEUTICAL CO.,LTD.
Cyfuse Biomedical K.K.
StemRIM Inc.
MEDICAL & BIOLOGICAL LABORATORIES CO.